Willner & Heller LLC Decreases Stake in Intuitive Surgical, Inc. $ISRG

Willner & Heller LLC lessened its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 5.9% during the 2nd quarter, according to its most recent disclosure with the SEC. The fund owned 3,436 shares of the medical equipment provider’s stock after selling 217 shares during the period. Intuitive Surgical accounts for about 1.6% of Willner & Heller LLC’s portfolio, making the stock its 10th largest position. Willner & Heller LLC’s holdings in Intuitive Surgical were worth $1,867,000 as of its most recent SEC filing.

Several other large investors also recently made changes to their positions in the business. Chilton Capital Management LLC boosted its holdings in Intuitive Surgical by 614.3% in the first quarter. Chilton Capital Management LLC now owns 50 shares of the medical equipment provider’s stock valued at $25,000 after acquiring an additional 43 shares during the last quarter. Elite Financial Inc. bought a new position in Intuitive Surgical in the first quarter valued at about $26,000. LFA Lugano Financial Advisors SA bought a new position in Intuitive Surgical in the first quarter valued at about $30,000. TD Capital Management LLC boosted its holdings in Intuitive Surgical by 300.0% in the first quarter. TD Capital Management LLC now owns 60 shares of the medical equipment provider’s stock valued at $30,000 after acquiring an additional 45 shares during the last quarter. Finally, 1248 Management LLC bought a new position in Intuitive Surgical in the first quarter valued at about $30,000. Institutional investors own 83.64% of the company’s stock.

Intuitive Surgical Trading Up 2.1%

Shares of ISRG opened at $452.35 on Friday. The company has a market capitalization of $162.16 billion, a price-to-earnings ratio of 63.09, a PEG ratio of 4.64 and a beta of 1.61. The stock has a 50 day moving average of $463.55 and a 200 day moving average of $500.00. Intuitive Surgical, Inc. has a 12 month low of $425.00 and a 12 month high of $616.00.

Intuitive Surgical (NASDAQ:ISRG) last announced its quarterly earnings results on Tuesday, July 22nd. The medical equipment provider reported $2.19 earnings per share for the quarter, beating the consensus estimate of $1.93 by $0.26. The company had revenue of $2.44 billion during the quarter, compared to analysts’ expectations of $2.35 billion. Intuitive Surgical had a return on equity of 14.56% and a net margin of 28.51%.The firm’s quarterly revenue was up 21.4% compared to the same quarter last year. During the same period in the previous year, the business earned $1.78 earnings per share. As a group, equities research analysts predict that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current year.

Insiders Place Their Bets

In related news, Director Amy L. Ladd sold 336 shares of the company’s stock in a transaction that occurred on Wednesday, September 3rd. The stock was sold at an average price of $470.11, for a total value of $157,956.96. Following the transaction, the director directly owned 1,074 shares of the company’s stock, valued at approximately $504,898.14. This represents a 23.83% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, insider Gary S. Guthart sold 29,360 shares of the stock in a transaction on Friday, August 29th. The shares were sold at an average price of $472.49, for a total value of $13,872,306.40. Following the transaction, the insider directly owned 19,827 shares in the company, valued at $9,368,059.23. The trade was a 59.69% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last quarter, insiders have sold 45,224 shares of company stock worth $21,716,492. Company insiders own 0.70% of the company’s stock.

Analyst Ratings Changes

Several equities analysts have weighed in on the company. Erste Group Bank reissued a “hold” rating on shares of Intuitive Surgical in a research note on Wednesday, July 23rd. Weiss Ratings reissued a “hold (c+)” rating on shares of Intuitive Surgical in a research note on Saturday, September 27th. Royal Bank Of Canada reissued an “outperform” rating and issued a $615.00 target price on shares of Intuitive Surgical in a research note on Tuesday, August 19th. The Goldman Sachs Group cut their target price on Intuitive Surgical from $621.00 to $567.00 and set a “buy” rating on the stock in a research note on Wednesday. Finally, Deutsche Bank Aktiengesellschaft reissued a “sell” rating on shares of Intuitive Surgical in a research note on Friday, August 22nd. Fourteen analysts have rated the stock with a Buy rating, seven have given a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat.com, Intuitive Surgical presently has a consensus rating of “Moderate Buy” and an average target price of $594.19.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.